Exchange
TSX
Every company in the roster listed on TSX.
Research
Compare financial metrics on this exchange
Research adds market cap, cash, runway and annualized R&D metrics with metric-specific sorting.
Views
3 of 3 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 Medicenna Therapeutics, Inc.MDNA · TSX | 2 assets: 1 Ph 2, 1 other | MDNA11Phase 1/2 · Non-Small Cell Lung Cancer | None on record |
 HLS Therapeutics Inc.HLS · TSX | 1 asset: 1 approved | Approved assets only | None on record |
 Helix BioPharma Corp.HBP · TSX | 1 asset: 1 Ph 2 | L-DOS47Phase 1/2 · Non-Small Cell Lung CancerWeak signal | None on record |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).